A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy Participants
A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy Participants
Recruiting · NCT07776782 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy Participants | Healthy Volunteer | Recruiting | Phase 1 | 2026-08-21 | NCT07776782 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mirador Therapeutics, Inc. | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mirador Clinical Department | San Diego | United States | 2 |